IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS
$11,573,495
| Recipient | ACCESS TO ADVANCED HEALTH INSTITUTE UEI EMQ1ANLATYS6 |
|---|---|
| Award ID | HHSN272201400041C |
| Award amount | $11,573,495 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Jul 23, 2014 |
| End date | Aug 31, 2022 |
| Place of performance | SEATTLE, WA |
| Record updated | Jul 8, 2022 |
View the official award record
More awards won by ACCESS TO ADVANCED HEALTH INSTITUTE
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
Department of Health and Human Services · $13,783,455 · Sep 9, 2019
IGF:OT::IGF - ADVANCED DEVELOPMENT AND CLINICAL EVALUATION OF A SYNTHETIC INTRANASAL ENTAMOEBA HISTOLYTICA VACCINE CONTAINING ADJUVANT.
Department of Health and Human Services · $11,260,157 · Sep 21, 2018
BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES
Department of Health and Human Services · $1,236,651 · Jul 5, 2023
INVESTIGATIONAL PRODUCTS GLA-SE ADJUVANT FORMULATION AND LYOPHILIZED ID93 FROM IDRI FOR DAIDS-FUNDED CLINICAL TRIALS
Department of Health and Human Services · $780,764 · Sep 3, 2021
INFECTIOUS DISEASE RESEARCH INSTITUTE: R&D OF INTRANASAL ADMINISTRATION OF RNA VACCINES AGAINST RESPIRATORY PATHOGENS
Department of Health and Human Services · $748,885 · Sep 20, 2021
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids